he 11 has been researched along with Atrial Fibrillation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Medvedev, MM; Rivin, AE; Shubik, IuV | 1 |
| Bil'dinov, OA; Bregvadze, IN; Chazov, EI; Golitsyn, SP; Klimenko, IuL; Kratskina, TL; Maĭkov, EB; Rozenshtraukh, LV; Smirnova, MIu; Sokolov, SF | 1 |
| Giliarov, MIu; Novikova, NA; Suchkova, SA; Sulimov, VA; Syrkin, AL | 1 |
| Chapurnykh, AV; Efremov, DN; Pavlov, EG; Solov'ev, OV; Zavalin, AV | 1 |
| Beloshapko, GG; Fedorov, VV; Rosenshtraukh, LV; Sharifov, OF; Yushmanova, AV | 1 |
1 trial(s) available for he 11 and Atrial Fibrillation
| Article | Year |
|---|---|
[Comparison of the efficacy and safety of electrical cardioversion and pharmacological cardioversion with nibentan in patients with persisting atrial fibrillation and flutter].
Topics: Atrial Fibrillation; Atrial Flutter; Benzamides; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2007 |
4 other study(ies) available for he 11 and Atrial Fibrillation
| Article | Year |
|---|---|
[Nibentan -- a drug for pharmacological cardioversion of persistent atrial fibrillation].
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Benzamides; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome | 2005 |
[The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Benzamides; Data Interpretation, Statistical; Electrocardiography; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Time Factors; Torsades de Pointes; Treatment Outcome | 2007 |
[Nibentan in arresting acute atrial fibrillation: risk or benefit?].
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Benzamides; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Treatment Outcome | 2008 |
Effects of a new class III antiarrhythmic drug nibentan in a canine model of vagally mediated atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzamides; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Electric Stimulation; Heart Rate; Vagus Nerve | 2000 |